Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 11 (1993), Issue 1, Pages 45-48
http://dx.doi.org/10.1155/1993/413530

An Assessment Of The Clinical Usefulness Of Two Serum Markers, CA 15 3 and HMFG 2 in Localized And Metastatic Breast Cancer

P. Bliss,1 J. Fiskent,2 J. Roulstent,2 and R. C. F. Leonard1

1Department of Clinical Oncology, Western General Hospital Edinburgh, University of Edinburgh, UK
2Department of Clinical Oncology, Western General Hospital Edinburgh and Clinical Chemistry, University of Edinburgh, UK

Received 24 July 1992; Accepted 16 October 1992

Copyright © 1993 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

P. Bliss, J. Fiskent, J. Roulstent, and R. C. F. Leonard, “An Assessment Of The Clinical Usefulness Of Two Serum Markers, CA 15 3 and HMFG 2 in Localized And Metastatic Breast Cancer,” Disease Markers, vol. 11, no. 1, pp. 45-48, 1993. doi:10.1155/1993/413530